Next Article in Journal
Using Physiologically Based Pharmacokinetic Models for Assessing Pharmacokinetic Drug–Drug Interactions in Patients with Chronic Heart Failure Taking Narrow Therapeutic Window Drugs
Next Article in Special Issue
A Review of the Clinical Progress of CT1812, a Novel Sigma-2 Receptor Antagonist for the Treatment of Alzheimer’s Disease
Previous Article in Journal
Regulation of Intestinal Barrier Function and Gut Microbiota by Hot Melt Extrusion-Drug Delivery System-Prepared Mulberry Anthocyanin in an Inflammatory Bowel Disease Model
Previous Article in Special Issue
Exploring Cannabinoids with Enhanced Binding Affinity for Targeting the Expanded Endocannabinoid System: A Promising Therapeutic Strategy for Alzheimer’s Disease Treatment
 
 
Article

Article Versions Notes

Pharmaceuticals 2025, 18(4), 476; https://doi.org/10.3390/ph18040476
Action Date Notes Link
article xml file uploaded 27 March 2025 13:28 CET Original file -
article xml uploaded. 27 March 2025 13:28 CET Update https://www.mdpi.com/1424-8247/18/4/476/xml
article pdf uploaded. 27 March 2025 13:28 CET Version of Record https://www.mdpi.com/1424-8247/18/4/476/pdf
article supplementary file uploaded. 27 March 2025 13:28 CET - https://www.mdpi.com/1424-8247/18/4/476#supplementary
article html file updated 27 March 2025 13:29 CET Original file https://www.mdpi.com/1424-8247/18/4/476/html
Back to TopTop